PLTR · Palantir Technologies Inc. · Stock research

é# PLTR — Palantir Technologies Inc.

Current Thesis

That close sits above the 200-day moving average of $152.54, which price had been trading below all through July, and it leaves an unfilled gap between the 2026-08-03 high of $126.97 and the 2026-08-04 low of $143.28.

The leg on offer is a growth re-acceleration that arrived while the multiple was at a three-year low. Q2 FY26 revenue was $1.935B, +93% YoY, against a company guide of $1.797–1.801B; US commercial revenue $764M, +149% YoY, up from +133% in Q1; FY26 revenue guidance to $8.150–8.158B from $7.650–7.662B; Q3 guided $2.160–2.164B against $1.997B consensus. The 10-Q filed 2026-08-04 adds the balance-sheet picture behind the headline: remaining performance obligations of $4.9B as of 2026-06-30, of which the company expects to recognise roughly 43% over the next twelve months and 36% over the following thirteen-to-twenty-four.

What has changed since the last note is not the fundamental case, which improved, but the entry structure, which deteriorated. The de-rating argument was made at $125.65. It is now being made at $162.66, and the buyer is paying for a one-session gap with nothing underneath it.

Bullish and bearish views on Palantir Technologies Inc.

The model's bull view on Palantir Technologies Inc. (PLTR), in brief: 2026-08-03: US commercial revenue $764M, +149% YoY. The bear view: A piece of the beat is a mark, not an operation. Both cases follow in full.

Bull Case

• 2026-08-03: US commercial revenue $764M, +149% YoY. The FY26 US commercial floor was lifted to more than $3.424B from more than $3.224B, moving the implied path from at least +120% to at least +134%. Total US revenue $1.573B, 81% of the quarter, versus 73% a year earlier (10-Q, 2026-08-04).
• 2026-08-04 (10-Q): remaining performance obligations $4.9B, the noncancelable contracted revenue not yet recognised. Contract liabilities $1.1B against $0.8B at 2025-12-31. Separately, the earnings deck put total remaining deal value at $13.1B, +83% YoY, and US commercial remaining deal value at $6.238B, +124% YoY.
• 2026-08-03: adjusted income from operations $1.194B on a 62% margin; GAAP income from operations $912.0M on a 47% margin against $269.3M a year earlier; adjusted free cash flow $1.220B on a 63% margin; Rule of 40 at 155%. Cash and equivalents $2.030B plus marketable securities $7.379B.
• Capital intensity is close to nil. Property and equipment, net was $61.4M against total assets of $11.679B at 2026-06-30 (10-Q). The growth is being produced without the balance-sheet build that the hyperscaler comparison implies.
• 2026-08-03 bookings: total contract value closed $3.373B, +49% YoY; US commercial TCV $2.132B, +153% YoY and a record; 220 deals above $1M, 98 above $5M, 73 above $10M;
• 2026-08-04 sell-side revisions: Citi to $245 from $200 (Buy); UBS to $220 (Buy); Mizuho to $215 (Outperform); Morgan Stanley $205 at Equal-weight, noting revenue growth has accelerated every quarter for three years running; DA Davidson to $200; William Blair upgraded to Outperform, arguing the quarter cuts against the view that OpenAI and Anthropic are taking enterprise AI workflow share.
• The multiple barely re-expanded through the move. Benzinga put trailing P/E at 129 and forward P/E at 83 on 2026-08-02 before the print. At the 2026-08-04 close of $162.66, stockanalysis.com showed trailing P/E 139.1 and forward P/E 86.2 — a 29% price move absorbed almost entirely by estimate revisions. (Different providers, different estimate sets; treat the comparison as directional.)

Bear Case

• A piece of the beat is a mark, not an operation. Other income (expense), net was $91.8M in Q2 FY26 against $6.6M in Q2 FY25 (10-Q). CFO David Glazer said on the call that unrealized gains on the SpaceX holding contributed $0.03 to GAAP EPS and $0.02 to adjusted EPS of $0.41. Publicly-traded equity securities were carried at $184.1M at 2026-06-30 versus $23.4M at 2025-12-31.
• That mark is already running the other way. SPCX closed $170.86 on 2026-06-30, the date Palantir struck its Q2 balance sheet, and $125.33 on 2026-08-04 — below its $135 IPO price of 2026-06-11 and more than 45% off the $225.64 peak of 2026-06-16. Unless SPCX recovers by 2026-09-30, the same income line reverses in Q3. This is an inference from two observable prices, not a company disclosure.
• The gap-and-fade precedent is eight days old. On 2026-07-27 the stock rose 7.00% to $131.53;
• The sell-side anchor has largely closed. Mean target across 32 analysts was $188.83 at the 2026-08-04 close (stockanalysis.com). Cantor Fitzgerald raised its target to $156 from $138 and kept a Neutral rating — a target below the closing price.
• International is shrinking as a share of the book. Rest-of-world revenue was $362.4M in Q2 FY26 against $271.1M a year earlier, but fell to 19% of total revenue from 27% (10-Q). France and Germany issued a joint declaration on 2026-07-17 pledging a European sovereign digital backbone; France's DGSI said in June 2026 it would move to ChapsVision's ArgonOS; Germany's BfV made the same call and the Bundeswehr has excluded Palantir from upcoming defence-cloud procurement. In Baden-Württemberg, Gotham was still not fully operational seventeen months after signature, with deployment now expected no earlier than end-2026.
• The adjusted-to-GAAP gap is stock compensation. Q2 SBC was $265.2M against $160.0M a year earlier; six-month SBC $466.8M against $315.3M. Unrecognised RSU expense was $916M at 2026-06-30, expected to run off over a weighted-average three years.
• Concentration cuts both ways. US government revenue was $809M of the $1.935B quarter. Budget cycles, continuing resolutions and procurement protests move that book independently of commercial AI demand, as the DIA ASTRA solicitation withdrawal on 2026-07-27 showed.
• Absolute valuation. Price/sales 63.5 and EV/EBITDA 143.4 at the 2026-08-04 close, against a market capitalisation of $390.88B.

Setup & Price Structure

Session detail for 2026-08-04: open $145.15, high $164.52, low $143.28, close $162.66, volume 174,591,298. The close came 1.1% off the session high, so the gap was held into the bell rather than distributed. The ten sessions before the print closed in a $122.26–$131.53 band, all of it below the 200-day moving average of $152.54; the 50-day sits at $130.99, roughly 24% below Tuesday's close. The 52-week range is $106.37–$207.52, with the low set 2026-06-25.

The structure to watch is the gap itself: $126.97 to $143.28, untouched. Price has no shelf inside it. Below the gap sits the $131.45 July triangle top that framed the pre-print range.

Life-cycle: ACCELERATING. The dating is 2026-08-03 to 2026-08-04 — a guidance raise of roughly $500M at the low end, a single-session volume expansion to roughly six times the recent baseline, six price-target increases and one upgrade inside one session, and an S&P 500 record-high tape on the same day. What would move the label to MATURING is volume normalising back toward 30–40 million shares while price holds the gap; what would move it to SATURATED is the sell-side mean ceasing to rise while retail-facing coverage keeps expanding.

Crowding and positioning observables, stated as observables: the close sits roughly 24% above the 50-day moving average; short interest was 77.88 million shares, 3.70% of float, at the 2026-08-04 reading — no squeeze structure; beta (5Y) 1.56. The most recent Form 4 on file, filed 2026-07-24 for a 2026-07-22 transaction, is a grant rather than a sale — 17,124 stock appreciation rights to the Chief Accounting Officer, struck at $135, exercisable only in a limited November 2035 window and only if the price exceeds $135 then, capped at $365 of appreciation. Form 4s are due within two business days, so any 2026-08-04 insider sales surface by 2026-08-06.

Catalyst Calendar (next 30 days)

• 2026-08-14 — Q2 2026 13F deadline. Covers the quarter that contained the 2026-06-25 low of $106.37, so it reports what institutions did into the drawdown, not into the gap.
• 2026-08-21 — August monthly options expiration, the first monthly with strikes written across the new $143–$165 range.
• ~2026-11-02 (est.) — Q3 FY26 results, outside the window but the number that grades this. Guided $2.160–2.164B. Date unconfirmed; providers also carry 2026-11-09.

Elapsed catalysts

• 2026-08-06 — Form 4 deadline for any insider transactions executed on 2026-08-04. Shows whether 10b5-1 supply met the gap. (passed 3d ago)
• 2026-08-07 — weekly options expiry, the first settlement after the event-vol collapse. Shows how much of the pre-print call-heavy positioning is carried through versus closed out. (passed 2d ago)

What Would Change Our Mind

The whole structure is one unfilled gap made in a single session. There is no base beneath $143.28 — the last price that traded before the gap was $126.97 on 2026-08-03 — so the first test is whether the range built on 2026-08-04 becomes support or becomes the high. A daily close below $143 puts price back inside that gap and points at the $131.45 July shelf, and the 2026-07-27/28 round trip is the recent precedent for exactly that.

Second, the growth term. US commercial at +149% YoY is what carries a forward multiple near 86 against a technology-sector median in the twenties. A Q3 print with US commercial growth below +120% YoY, against the at-least-+134% FY26 path management guided on 2026-08-03, removes the term that justifies the multiple even if the revenue line lands inside the $2.160–2.164B guide.

Third, the earnings quality. If the Q3 income statement shows a negative swing in other income, net — plausible with SPCX at $125.33 on 2026-08-04 versus the $170.86 mark of 2026-06-30 — the GAAP EPS comparison gets harder in a quarter where the operating story has to carry it alone.

Fourth, the label. Volume decaying below the pre-print baseline while sell-side targets stop rising would date the shift from ACCELERATING toward SATURATED, and the marginal bid that took price 29% higher in a day would be the thing that is missing.

Correlation Notes

• SPCX is now a direct, mechanical link to Palantir's GAAP income statement through the equity mark, and it is not a link that runs with Palantir's own results. SPCX reported after the close on 2026-08-04 and reversed lower in the after-hours session.
• Long-duration software multiples. With trailing P/E 139.1 and price/sales 63.5, the discount rate matters more here than for most large caps; beta of 1.56 understates the sensitivity to a rate repricing.
• AI capex complex. Palantir's own capital intensity is minimal ($61.4M property and equipment, net), so it trades with the AI narrative without carrying the capex, which makes it a poor hedge for hyperscaler spending disappointment and a good beneficiary of the narrative that survives one.
• US federal budget cycle. With $809M of the quarter from US government and 81% of revenue from the United States, appropriations and continuing-resolution mechanics move the book independently of the commercial AI cycle.
• Index. The S&P 500 closed at record highs on 2026-08-04 with PLTR contributing; a large single-name move inside a strong tape is harder to attribute to name-specific demand than the same move on a flat one.